Forest Launches Alcoholism Drug Campral Through Antidepressant Sales Reps
This article was originally published in The Pink Sheet Daily
Executive Summary
Lipha/Forest's alcoholism treatment Campral (acamprosate) will be available at an average wholesale price of about $4.36 per day
You may also be interested in...
Forest Ends Daiichi Azor Deal To Focus On Its Own Products
Japanese pharma gets $26 million break-up fee as co-promotion ends.
Forest Ends Daiichi Azor Deal To Focus On Its Own Products
Japanese pharma gets $26 million break-up fee as co-promotion ends.
Forest/Lipha Campral Approved On Re-Audit; FDA Backs Off Additional Study Request
Alcoholism agent Campral skirts additional trial requirement via re-audit of European data to address data handling concerns, FDA review documents show. Issues of concern include “sloppy” data collection and poorly defined primary endpoints. Re-working of data from three pivotal, non-U.S. studies overturns June 2002 “not approvable” finding.